Susquehanna International Group
GMAB icon

Susquehanna International Group’s Genmab GMAB Stock Holding History

Susquehanna International Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,900
Closed -$705K – 13507
2025
Q4 		$705K Buy
+22,900
New +$714K ﹤0.01% 8009
2025
Q3 		– Sell
-16,900
Closed -$349K – 12953
2025
Q2 		$349K Buy
16,900
+4,200
+33% +$86.2K ﹤0.01% 10001
2025
Q1 		$249K Sell
12,700
-12,500
-50% -$262K ﹤0.01% 10487
2024
Q4 		$526K Buy
25,200
+7,900
+46% +$174K ﹤0.01% 8537
2024
Q3 		$422K Buy
17,300
+2,700
+18% +$72.2K ﹤0.01% 8875
2024
Q2 		$367K Sell
14,600
-10,300
-41% -$292K ﹤0.01% 9009
2024
Q1 		$745K Buy
+24,900
New +$731K ﹤0.01% 7571
2023
Q4 		– Sell
-18,000
Closed -$635K – 12695
2023
Q3 		$635K Buy
18,000
+5,000
+38% +$191K ﹤0.01% 7680
2023
Q2 		$494K Sell
13,000
-88,000
-87% -$3.51M ﹤0.01% 8347
2023
Q1 		$3.81M Buy
101,000
+74,500
+281% +$2.86M ﹤0.01% 3867
2022
Q4 		$1.12M Buy
+26,500
New +$1.09M ﹤0.01% 5910
2022
Q1 		– Sell
-6,700
Closed -$265K – 13367
2021
Q4 		$265K Sell
6,700
-6,600
-50% -$275K ﹤0.01% 10781
2021
Q3 		$581K Sell
13,300
-7,300
-35% -$328K ﹤0.01% 8983
2021
Q2 		$841K Sell
20,600
-55,700
-73% -$2.15M ﹤0.01% 8240
2021
Q1 		$2.5M Buy
76,300
+34,900
+84% +$1.31M ﹤0.01% 5373
2020
Q4 		$1.68M Buy
41,400
+4,400
+12% +$164K ﹤0.01% 5476
2020
Q3 		$1.35M Buy
37,000
+28,600
+340% +$1.03M ﹤0.01% 5391
2020
Q2 		$285K Buy
+8,400
New +$229K ﹤0.01% 8447

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Susquehanna International Group's GMAB Position: Q1 2026 in Review

Susquehanna International Group sold out of Genmab (GMAB) in Q1 2026, closing a stake of 612,323 shares — an estimated $18.4M sold.

Susquehanna International Group first reported a position in GMAB in Q4 2019 and held it in 22 quarters. The position peaked at $18.9M in Q4 2025. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Susquehanna International Group reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 612,323 Genmab shares in Q1 2026, an estimated $18.4M.
  • Susquehanna International Group first reported a position in Genmab in Q4 2019 and held it in 22 quarters.
  • Susquehanna International Group's Genmab position peaked at $18.9M in Q4 2025.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.